Volume 16, Issue 2 pp. 130-134

Detection of down-regulated acetaldehyde dehydrogenase 1 in atopic dermatitis patients by two-dimensional electrophoresis

Yong-Doo Park

Yong-Doo Park

Department of Dermatology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea;

Clinical Research Center, Samsung Biomedical Research Institute, Seoul, Korea

Search for more papers by this author
You-Jeong Lyou

You-Jeong Lyou

Clinical Research Center, Samsung Biomedical Research Institute, Seoul, Korea

Search for more papers by this author
Jun-Mo Yang

Jun-Mo Yang

Department of Dermatology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea;

Clinical Research Center, Samsung Biomedical Research Institute, Seoul, Korea

Search for more papers by this author
First published: 03 January 2007
Citations: 16
Jun-Mo Yang, MD, PhD, Department of Dermatology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul 135-710, Korea, Tel.: +82 2 3410 3541, Fax: +82 2 3410 3869, e-mail: [email protected]

Abstract

Abstract: We conducted the proteomic studies to detect the dysregulated proteins in the atopic dermatitis (AD) proteome obtained from the patient-derived primary cultured fibroblasts. Acetaldehyde dehydrogenase 1 (ALDH1) was detected as being significantly down-regulated at the pH ranges of 6–9 and 4–7. The transcriptional levels of ALDH1, as detected by RT-PCR and real-time PCR, further confirmed the down-regulated phenomena for all the AD-fibroblasts (n = 20). The expression levels of ALDH1 in the whole skin tissue samples were further supported by the results of the primary cultured samples. These findings clearly demonstrate that ALDH1 can be a dermal biomarker for AD disease.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.